| Elevated human epididymis protein 4 concentrations in chronic kidney disease B Nagy Jr, ZT Krasznai, H Balla, M Csobán, P Antal-Szalmás, Z Hernádi, ... Annals of clinical biochemistry 49 (4), 377-380, 2012 | 151 | 2012 |
| Gadolinium, a mechano‐sensitive channel blocker, inhibits osmosis‐initiated motility of sea‐and freshwater fish sperm, but does not affect human or ascidian sperm motility Z Krasznai, M Morisawa, ZT Krasznai, S Morisawa, K Inaba, ZK Bazsáné, ... Cell motility and the cytoskeleton 55 (4), 232-243, 2003 | 93 | 2003 |
| Role of ion channels and membrane potential in the initiation of carp sperm motility Z Krasznai, M Morisawa, S Morisawa, ZT Krasznai, L Trón, R Gáspár, ... Aquatic Living Resources 16 (5), 445-449, 2003 | 87 | 2003 |
| The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling A Sipos, G Ujlaki, E Mikó, E Maka, J Szabó, K Uray, Z Krasznai, P Bai Molecular Medicine 27, 1-20, 2021 | 78 | 2021 |
| Role of the Na+/Ca2+ exchanger in calcium homeostasis and human sperm motility regulation Z Krasznai, ZT Krasznai, M Morisawa, ZK Bazsáné, Z Hernádi, Z Fazekas, ... Cell motility and the cytoskeleton 63 (2), 66-76, 2006 | 70 | 2006 |
| Duration of HPV-associated risk for high-grade cervical intraepithelial neoplasia Z Hernádi, L Gazdag, K Szőke, T Sápy, ZT Krasznai, J Kónya European Journal of Obstetrics & Gynecology and Reproductive Biology 125 (1 …, 2006 | 56 | 2006 |
| Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions Z Hernádi, K Szőke, T Sápy, ZT Krasznai, G Soós, G Veress, L Gergely, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 118 (2 …, 2005 | 40 | 2005 |
| The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up Z Hernádi, K Szarka, T Sápy, Z Krasznai, G Veress, R Póka BJOG: an international journal of obstetrics and gynaecology 110 (2), 205-209, 2003 | 34 | 2003 |
| Seminal vesicle secretion 2 acts as a protectant of sperm sterols and prevents ectopic sperm capacitation in mice N Araki, G Trencsényi, ZT Krasznai, E Nizsalóczki, A Sakamoto, ... Biology of reproduction 92 (1), 8, 1-10, 2015 | 32 | 2015 |
| Moderate variation of the oncogenic potential among high‐risk human papillomavirus types in gynecologic patients with cervical abnormalities K Szőke, T Sápy, Z Krasznai, Z Hernádi, G Szládek, G Veress, J Dillner, ... Journal of medical virology 71 (4), 585-592, 2003 | 31 | 2003 |
| Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer ZT Krasznai, E Friedländer, A Nagy, G Szabó, G Vereb, K Goda, ... Anticancer research 25 (2A), 1187-1192, 2005 | 30 | 2005 |
| Dysmenorrhea in adolescent girls AG Juhász, G Vincze, Z Krasznai, R Csorba, T Major Orvosi hetilap 146 (1), 27-32, 2005 | 30 | 2005 |
| Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans K Yoshida, ZT Krasznai, Z Krasznai, M Yoshiike, N Kawano, M Yoshida, ... Cell Motility and the Cytoskeleton 66 (2), 99-108, 2009 | 27 | 2009 |
| Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG ZT Krasznai, Á Tóth, P Mikecz, Z Fodor, G Szabó, L Galuska, Z Hernádi, ... European Journal of Pharmaceutical Sciences 41 (5), 665-669, 2010 | 26 | 2010 |
| Biphasic accumulation kinetics of [99mTc]-hexakis-2-methoxyisobutyl isonitrile in tumour cells and its modulation by lipophilic P-glycoprotein ligands T Márián, L Balkay, G Szabó, ZT Krasznai, Z Hernádi, L Galuska, ... European journal of pharmaceutical sciences 25 (2-3), 201-209, 2005 | 23 | 2005 |
| Effects of miltefosine on membrane permeability and accumulation of [99mTc]-hexakis-2-methoxyisobutyl isonitrile, 2-[18F] fluoro-2-deoxy-D-glucose, daunorubucin and … T Márián, L Balkay, L Trón, ZT Krasznai, J Szabó-Péli, Z Krasznai European journal of pharmaceutical sciences 24 (5), 495-501, 2005 | 19 | 2005 |
| Intention-to-treat analysis of radical trachelectomy for early-stage cervical cancer with special reference to oncologic failures: single-institutional experience in Hungary R Póka, S Molnár, P Daragó, J Lukács, R Lampé, Z Krasznai, Z Hernádi International Journal of Gynecologic Cancer 27 (7), 2017 | 15 | 2017 |
| The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity G Szalóki, ZT Krasznai, Á Tóth, L Vízkeleti, AG Szöllősi, G Trencsényi, ... PloS one 9 (9), e107875, 2014 | 12 | 2014 |
| The role of hysteroscopy during COVID‐19 outbreak: Safeguarding lives and saving resources SG Vitale, J Carugno, G Riemma, Z Farkas, Z Krasznai, G Bacskó, ... International Journal of Gynaecology and Obstetrics 150 (2), 256, 2020 | 11 | 2020 |
| 18FDG a PET tumor diagnostic tracer is not a substrate of the ABC transporter P-glycoprotein ZT Krasznai, G Trencsényi, Z Krasznai, P Mikecz, E Nizsalóczki, G Szalóki, ... European Journal of Pharmaceutical Sciences 64, 1-8, 2014 | 11 | 2014 |
